Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Collaborate to Survive

In a PM Live guest blog this month, Dovetail’s Director, Claire Munro argues that for companies to survive the raft of major changes affecting pharma, they need to get better...

Dovetail

Lucid expands both UK and US operations with new hires

Lucid bolsters their client services and facilities teams and spread their magic across the globe with new hires. Cindy Miller joins the Lighthouse team as an Account Director in the...

Lucid Group Communications Limited

- PMLiVE

GSK: we won’t be splitting up any time soon

Walmsley scotches rumours of a consumer health spin-off

- PMLiVE

Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down

News from pharma, biotech and healthcare

AstraZeneca AZ

New cancer drugs can’t quite plug the revenue hole at AZ

Overall sales fell 5% to $10.33bn

- PMLiVE

Communication is the key to unlocking the potential of immuno-oncology

Communication is a necessity, not an option

Biogen Idec building

Big debate follows Biogen/Eisai’s Alzheimer’s study unveiling

Mixed results prompted a 10% share drop for both companies

Collaborate to survive

The pharma and life sciences industries are being buffeted by major shifts in technology, data, funding, demographics and patient expectations – all happening at the same time. According to industry...

Inside the patient-centricity bubble

Patient-centricity has become somewhat of a fixed mantra lately and pharma seems more than happy to join in with the chant. But despite the danger of becoming a cliché, if...

- PMLiVE

Daily Brief: GSK unveils R&D plan, Keytruda OK’d for lymphoma by NICE

News from pharma, biotech and healthcare

- PMLiVE

Minister reveals medicines stockpiling plan for No Deal Brexit

Hancock says plans being made - but will come at a cost

- PMLiVE

AbbVie’s blockbuster-in-waiting for endometriosis gets FDA nod

First new oral treatment in more than 10 years

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links